• Home
  • About APS
  • APS News
  • Job Postings and Ads
  • Events and Education
  • Goverment Affairs
  • 2024 Annual Meeting
  • Education-OUD
  • Education-On Demand
  • Mental Health Resources

To Buy Strattera Online Visit Our Pharmacy ↓

Click HERE To Buy Strattera Online ↓




  • Exploring Long-term Use of Strattera: What to Expect

    Understanding Strattera: a Non-stimulant Adhd Medication


    Strattera, known generically as atomoxetine, is an innovative option in the realm of ADHD treatments. Unlike traditional stimulant medications, Strattera works by selectively inhibiting the reuptake of norepinephrine, a neurotransmitter linked to attention and impulse control. This distinct mechanism provides an alternative for those for whom stimulants are unsuitable, offering a steadier effect without the peaks and troughs often associated with stimulant use.

    Despite its non-stimulant nature, Strattera's effectiveness is noteworthy. It promotes enhanced focus and reduced hyperactivity, supporting better productivity and cognitive function over time. Patients often appreciate the lack of euphoria or heightened anxiety that can accompany stimulant medications, allowing for a more natural rhythm in daily activities.

    | Feature | Strattera | |---------------------|------------------------------------------| | Type | Non-stimulant | | Mechanism | Norepinephrine reuptake inhibitor | | Main Benefits | Consistent effects, minimal anxiety | | Suitability | For those who can’t tolerate stimulants |

    This gradual therapeutic impact makes it a viable option for sustained ADHD management, fostering greater compliance and potentially long-lasting improvements in quality of life.



    Potential Benefits of Strattera for Long-term Use



    For individuals managing ADHD over the long term, Strattera can offer a unique set of benefits distinct from traditional stimulant medications. Known scientifically as atomoxetine, Strattera acts by influencing norepinephrine levels in the brain, providing a less intense but sustained effect. This can be particularly advantageous for those seeking stability in their symptoms without the peaks and troughs sometimes associated with stimulants.

    Furthermore, Strattera is less likely to lead to dependency, making it a suitable choice for those concerned about medication misuse. It can also complement other therapeutic approaches, allowing individuals to maintain a more consistent daily routine and achieve better overall life management.



    Navigating Side Effects: What Patients May Experience


    For individuals embarking on the journey of long-term Strattera use, understanding potential side effects is crucial. Strattera, unlike stimulant medications, affects norepinephrine levels in the brain, which can sometimes lead to side effects. Commonly reported issues include dry mouth, decreased appetite, fatigue, and gastrointestinal discomfort. Patients should not be alarmed, as these symptoms often diminish over time as the body adjusts to the medication.

    However, some individuals may experience mood changes or increased heart rate. It's essential to maintain open communication with healthcare providers to tailor the treatment plan as needed. Regular monitoring can help mitigate more severe side effects and ensure a more comfortable experience while using Strattera.

    Combining Strattera with lifestyle changes, like improved diet and exercise regimens, can further alleviate some of these effects and enhance overall well-being. Understanding one's unique response to the medication can empower patients to navigate their ADHD treatment effectively.



    Strattera and Lifestyle Changes: a Balanced Approach



    Incorporating Strattera into daily life requires more than just taking a pill; it involves a holistic approach to managing ADHD effectively. Strattera acts on norepinephrine levels, potentially enhancing focus and reducing impulsivity, but achieving the best outcomes often hinges on complementary lifestyle adjustments. Regular exercise can amplify Strattera’s benefits, as physical activity is known to boost mood and improve concentration. Additionally, a balanced diet rich in omega-3 fatty acids, proteins, and complex carbohydrates may further stabilize energy levels and cognitive function.

    Mindfulness practices, such as meditation or yoga, can provide essential support, helping individuals manage stress and increase attention span. Establishing a consistent sleep routine is also crucial, as adequate rest aids in cognitive processing and overall emotional regulation. By integrating these lifestyle changes, individuals using Strattera may find a more harmonious path to managing their ADHD symptoms, promoting both mental and physical well-being.



    Long-term Studies: Insights from Recent Research


    Recent research on Strattera, a non-stimulant prescribed to manage ADHD symptoms, sheds light on its long-term efficacy and safety profile. Studies suggest that consistent use can lead to sustained improvements in attention and impulse control, key challenges faced by adults and children with ADHD. This success is largely attributed to Strattera’s ability to enhance norepinephrine levels in the brain, thereby mitigating common symptoms without the heightened risk of dependence associated with stimulant medications.

    However, it's crucial to weigh these benefits against emerging data about potential long-term side effects. Researchers have observed that while most patients tolerate Strattera well, some experience persistent issues such as decreased appetite or sleep disturbances. These side effects highlight the importance of regular medical evaluations to adjust dosages as necessary and ensure patient well-being over time.

    Long-term Study Focus Findings
    Efficacy in symptom control Sustained improvement in attention and impulse control
    Common side effects Decreased appetite and sleep issues

    Overall, the growing body of evidence suggests that with careful management, Strattera offers a promising pathway for chronic ADHD management, especially for patients seeking a non-stimulant option. Continued research will pave the way for more tailored treatment strategies, offering a clearer understanding of how Strattera can be optimally integrated into long-term ADHD management plans.



    Expert Tips for Managing Adhd with Strattera


    For those navigating ADHD management with Strattera, it’s essential to maintain consistent communication with your healthcare provider. Regular check-ins can help track progress, address any emerging side effects, and adjust dosages effectively. Additionally, considering a holistic approach that integrates behavioral therapy can enhance the medication's effectiveness.

    Developing a supportive routine can play a crucial role. This might include establishing a structured daily schedule, utilizing organizational tools, and setting realistic goals to measure personal progress. Such strategies can aid in creating a more balanced lifestyle.

    Lastly, engage in healthy lifestyle habits, including a balanced diet and regular physical activity, as they can augment the benefits of Strattera. Incorporating mindfulness practices, like meditation or yoga, can help reduce stress and improve focus. Leveraging both medical insights and lifestyle tweaks offers a comprehensive path to managing ADHD effectively.





ARIZONA PSYCHIATRIC SOCIETY 2024-2025 EXECUTIVE Board

President: Nicholas Ahrendt, MD President-Elect: Margaret Balfour, MD, PhDVice President: Brenner Freeman, MDTreasurer: Robert Rymowicz, DOSecretary: Chiranjir "Ravi" Narine, MD Co Resident-Fellow Member Representatives: Nehal Samra, MD Creighton Matthew Mitchell, MD UA-PhoenixGagan Singh, MD UA-Tucson
APA Assembly Representatives: Jason Curry, DO (serves term concluding 2024) Jasleen Chhatwal, MBBS, MD (two-year term concluding 2024)Payam Sadr, MD (one-year term concluding 2024) Past President Gagandeep Singh, MD, DFAPA Stephen "Larry" Mecham, DO The Society thanks these members for their leadership.

Celebrating our members

Chase was born and raised in Phoenix, AZ, and attended ASU for a bachelor’s degree in business then attended KCUMB for medical school in Kansas City. He was excited to return home to AZ when he found out he'd been matched with UACOM – Phoenix for his psychiatry residency.
He was first drawn to the field of psychiatry during his years in medical school as he found the psychiatric subject matter and the patients to be the most engaging and interesting of all his studies. He quickly came to realize that without a healthy mind, one is unable to thoroughly experience life constructive way. He wanted to be the person to help those struggling with mental illness as he found these cases and experiences to be the most rewarding in medicine.
Dr. Crookham said he has been lucky enough to have been matched at a great psychiatric residency program where he gets to learn from great mentors and colleagues every day. He believes his passion for psychiatry along with the relationships he's developed with his colleagues and mentors will carry him to be a lifelong learner and devoted psychiatrist for his future patients.
Meghan is a graduate of Lincoln Memorial University, DeBusk College of Osteopathic Medicine.
She received her Bachelor of Arts from the University of Denver in French and Biology with a concentration in Cognitive Neuroscience.
She is currently a chief resident at UACOM-Tucson in her final year of psychiatry training and will be starting a fellowship in Addiction Medicine at the University of Arizona, Tucson in July.
Her professional interests include physician mental health, adult consult liaison and addiction psychiatry.
In her personal time, she enjoys home design projects, spending time with family, learning about plants, and exploring new places.
Dr. Hintze is currently honeymooning in Japan! Congratulations!!
Danny is originally from Phoenix. Graduated from Brophy, ASU, and UA Tucson Medical School. His background is in economics, philosophy of science, and rational decision-making.
He was drawn to psychiatry because of the conceptual complexity and the profound impact even relatively simple pharmaceutical, medical, and psychotherapeutic interventions can have to empower patients and their families.
As a mentor, he wanted to recognize the many people within the Arizona Medical Community, particularly at UA Tucson, Valleywise, and within organized medicine who have worked to protect and promote medicine as a joyful, compassionate, and healing experience for patients and for all of us who help care for them.

ARIZONA PSYCHIATRIC SOCIETY past presidents

Otto L. Bendheim, M.D. 1960-1961Warren S. Williams, M.D. 1961-1963T. Richard Gregory, M.D. 1963-1964Boris Zemsky, M.D. 1964-1965 Hal J. Breen, M.D. 1965-1966Joseph M. Green, M.D. 1966-1967Irene M. Josselyn, M.D. 1967-1968Hubert R. Estes, M.D. 1968-1969Richard H. Bruner, M.D. 1969-1970Thomas F. Kruchek, M.D. 1970-1971David S. Burgoyne Sr., M.D. 1971-1972Marshall W. Jones, M.D. 1972-1973Harold D. Haeussler, M.D. 1973-1974William B. Haeussler, M.D. 1974-1975Edward S. Gelardin, M.D. 1975-1976Hugo L. Cozzi, M.D. 1976-1977Robert F. Meyer, M.D. 1977-1978James E. Campbell, M.D. 1978-1979Stuart M. Gould, M.D. 1979-1980Elliot M. Heiman, M.D. 1980-1981Stephen V. Shanfield, M.D. 1981-1982Jerry A. Biggs, M.D. 1982-1983Robert C. Shapiro, M.D. 1983-1984Dennis C. Westin, M.D. 1984-1985John H. Jarvis, M.D. 1985-1986James G. Hill, M.D. 1986-1987Robert P. Bevan, M.D. 1987-1988Eugene J. Kinder, M.D. 1988-1989 James M. Campbell, M.D. 1989-1990David S. Burgoyne II, M.D. 1990-1991
Stuart W. Hollingsworth, M.D. 1991-1992Kevin J. Leehey, M.D. 1992-1993Stephen S. Brockway, M.D. 1993-1994Michael H. Stumpf, M.D. 1994-1995Lauro Amezcua-Patino, M.D. 1995-1996David S. Burgoyne II, M.D. 1997-1998Glenn Lippman, M.D. 1998-1999Lisa Jones, M.D. 1999-2000David J. Coons, M.D. 2000-2001James M. Campbell, M.D. 2001-2002Bradley Johnson, M.D. 2002-2003David W. Leicken, M.D. 2003-2004Thomas N. Crumbley, M.D. 2004-2006Jeffrey L. Schwimmer, M.D., M.P.H. 2006-2007Stephen O. Morris, M.D. 2007-2008Jack L. Potts, M.D. 2008-2009Elizabeth A. Kohlhepp, M.D. 2009-2010Michael E. Brennan, M.D. 2010-2011Gretchen Alexander, M.D. 2011-2012Tariq M. Ghafoor, M.D. 2012-2013Joanna K. Kowalik, M.D., M.P.H., 2013-2014Payam M. Sadr, M.D., 2014-2015Roland Segal, M.D., 2015-2016Gurjot Marwah, M.D., 2016-2017Aaron Wilson, M.D., 2017-2018Mona Amini, M.D., 2018-2019 Don J. Fowls, M.D., 2019-2020 Jasleen Chhatwal, M.B.B.S., M.D., 2020-2022 Stephen Larry Mecham, DO, 2022-2023 Gagandeep Singh, MD, DFAPA 2023-2024
Main Menu
  • Home
  • About APS
  • APS News
  • Job Postings and Ads
  • Events and Education
  • 2023 Annual Meeting
  • Education-OUD
  • Education-On Demand
  • Mental Health Resources
Contact Information
Address: 2401 West Peoria Avenue, Suite 315 Phoenix, Arizona 85029
Phone: 602-909-4388
E-mail: admin@azpsych.org
Social
The Arizona Psychiatric Society is committed to ensuring the accessibility of its website to people with disabilities. If you have trouble accessing any of the Arizona Psychiatric Society's resources, please contact us at admin@azpsych.org for assistance Copyright © 2020 Network Solutions, LLC, A Web.com Company. All rights reserved.

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept you consent to our use of cookies. Read about how we use cookies.

Your Cookie Settings

We use cookies to enable essential functionality on our website, and analyze website traffic. Read about how we use cookies.

Cookie Categories
Essential

These cookies are strictly necessary to provide you with services available through our websites. You cannot refuse these cookies without impacting how our websites function. You can block or delete them by changing your browser settings, as described under the heading "Managing cookies" in the Privacy and Cookies Policy.

Analytics

These cookies collect information that is used in aggregate form to help us understand how our websites are being used or how effective our marketing campaigns are.